アルツハイマー診断テスト:医療機器パイプライン分析

◆英語タイトル:Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0189
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:431
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥848,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,272,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019″ provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Alzheimer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 12
1.2 List of Figures 20
2 Introduction 21
2.1 Alzheimer Diagnostic Tests Overview 21
3 Products under Development 22
3.1 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 22
3.2 Alzheimer Diagnostic Tests – Pipeline Products by Territory 23
3.3 Alzheimer Diagnostic Tests – Pipeline Products by Regulatory Path 24
3.4 Alzheimer Diagnostic Tests – Pipeline Products by Estimated Approval Date 25
3.5 Alzheimer Diagnostic Tests – Ongoing Clinical Trials 26
4 Alzheimer Diagnostic Tests – Pipeline Products under Development by Companies 27
4.1 Alzheimer Diagnostic Tests Companies – Pipeline Products by Stage of Development 27
4.2 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 32
5 Alzheimer Diagnostic Tests Companies and Product Overview 37
6 Alzheimer Diagnostic Tests – Recent Developments 191
7 Appendix 419

List of Tables
Table 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
Table 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
Table 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Table 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Table 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26
Table 6: Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
Table 7: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 32
Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 37
Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status 37
Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description 38
Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status 38
Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description 38
Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 39
Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status 39
Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description 39
Table 16: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 40
Table 17: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 40
Table 18: Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status 41
Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description 41
Table 21: Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 22: Diagnostic Assay - Alzheimer’s Disease - Product Status 42
Table 23: Diagnostic Assay - Alzheimer’s Disease - Product Description 42
Table 24: Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 43
Table 25: Diagnostic Test - Alzheimer's Disease - Product Status 43
Table 26: Diagnostic Test - Alzheimer's Disease - Product Description 43
Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44
Table 28: ADDL'S Biomarker Test - Product Status 44
Table 29: ADDL'S Biomarker Test - Product Description 45
Table 30: Biomarker Assay - Amyloid Ratio High Sensitivity - Product Status 45
Table 31: Biomarker Assay - Amyloid Ratio High Sensitivity - Product Description 45
Table 32: Biomarker Assay - P-Tau Isoforms - Product Status 46
Table 33: Biomarker Assay - P-Tau Isoforms - Product Description 46
Table 34: Biomarker Assay - Tau Isoforms - Product Status 46
Table 35: Biomarker Assay - Tau Isoforms - Product Description 46
Table 36: Blood Based Amyloid Beta Biomarker Test - Product Status 47
Table 37: Blood Based Amyloid Beta Biomarker Test - Product Description 47
Table 38: GLOB. P3N Aß Biomarker Test - Product Status 47
Table 39: GLOB. P3N Aß Biomarker Test - Product Description 48
Table 40: O-TAU Biomarker Test - Product Status 48
Table 41: O-TAU Biomarker Test - Product Description 48
Table 42: SNAP 25 Biomarker Test - Product Status 49
Table 43: SNAP 25 Biomarker Test - Product Description 49
Table 44: Synuclein Oligo Biomarker Test - Product Status 49
Table 45: Synuclein Oligo Biomarker Test - Product Description 50
Table 46: Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 51
Table 47: Diagnostic Blood Test - Alzheimer's Disease - Product Status 51
Table 48: Diagnostic Blood Test - Alzheimer's Disease - Product Description 51
Table 49: Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 52
Table 50: Diagnostic Test - Alzheimer's Disease - Product Status 52
Table 51: Diagnostic Test - Alzheimer's Disease - Product Description 52
Table 52: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 53
Table 53: Mitochondrial Preprotein Based Test - Alzheimer’s Disease - Product Status 53
Table 54: Mitochondrial Preprotein Based Test - Alzheimer’s Disease - Product Description 53
Table 55: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 56: Diagnostic Assay - Alzheimer’s Disease - Product Status 54
Table 57: Diagnostic Assay - Alzheimer’s Disease - Product Description 54
Table 58: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 59: Diagnostic Test - Alzheimer’s Disease - Product Status 55
Table 60: Diagnostic Test - Alzheimer’s Disease - Product Description 55

List of Figures
Figure 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
Figure 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
Figure 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Figure 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Figure 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アルツハイマー診断テスト:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆